Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Rosario González Mancha"'
Autor:
Rosario González Mancha, Montserrat Muñoz, Luis de la Cruz-Merino, Lourdes Calvo, Josefina Cruz, Jose Manuel Baena-Cañada, Yolanda Fernandez, Manuel Ramos, Cesar Augusto Rodriguez, Jose Ignacio Chacón, Isabel Palomero, Julia Llinares, María Rivero, Miguel Ángel Ruiz
Publikováno v:
Health and Quality of Life Outcomes, Vol 17, Iss 1, Pp 1-9 (2019)
Abstract Purpose Because the currently available questionnaires to evaluate sexual changes on breast cancer women only address the sexual sphere with a few questions our purpose was to develop a questionnaire that assesses changes in sexual dysfuncti
Externí odkaz:
https://doaj.org/article/062ded86af0c44f1bbcd0c0451541c54
Autor:
Daniel Herrero, María Rocío Morales Herrero, José Luis López Guerra, Alberto Sánchez Camacho-Mejías, Irene Carrasco García, Paloma Santos Fernández, Carmen Victoria Almeida González, Marta Benavent Viñuales, Alejandro Falcón González, Álvaro Montaño Periáñez, Rosario González Mancha, Francisco Javier Salvador Bofill, Manuel Ruiz Borrego
Publikováno v:
Archives of Breast Cancer (2020)
Background: Male breast cancer (MBC) accounts for less than 1% of breast cancer, requiring extrapolation of results from studies in women. The aim of the study is to evaluate prognostic and therapeutic factors with special focus in endocrine treatmen
Externí odkaz:
https://doaj.org/article/027c49113f9b4b1c8ba36b809b762643
Autor:
Alberto Sánchez Camacho-Mejías, Daniel Herrero, Carmen Victoria Almeida González, Marta Benavent Viñuales, Irene Carrasco García, María Rocío Morales Herrero, Manuel Ruiz Borrego, Jose Luis Lopez Guerra, Francisco Javier Salvador Bofill, Paloma Santos Fernández, Rosario González Mancha, Álvaro Montaño Periáñez, Alejandro González
Publikováno v:
Archives of Breast Cancer (2020)
Background: Male breast cancer (MBC) accounts for less than 1% of breast cancer, requiring extrapolation of results from studies in women. The aim of the study is to evaluate prognostic and therapeutic factors with special focus in endocrine treatmen
Autor:
Yolanda Fernández, Rosario González Mancha, Julia Llinares, Montserrat Muñoz, César A. Rodríguez, Miguel A. Ruiz, Lourdes Calvo, María Rivero, José Manuel Baena-Cañada, Jose Ignacio Chacon, Josefina Cruz, Isabel Palomero, Luis de la Cruz-Merino, Manuel Ramos
Publikováno v:
Health and Quality of Life Outcomes, Vol 17, Iss 1, Pp 1-9 (2019)
Health and Quality of Life Outcomes
Health and Quality of Life Outcomes
Purpose Because the currently available questionnaires to evaluate sexual changes on breast cancer women only address the sexual sphere with a few questions our purpose was to develop a questionnaire that assesses changes in sexual dysfunction and sa
Autor:
Rosario González Mancha, José Manuel Baena Cañada, Gumersindo Pérez Manga, Enrique Aguilar, Pedro Sánchez Rovira, Juan de la Haba-Rodriguez, Emilio Alba Conejo
Publikováno v:
Clinical breast cancer. 10(4)
Background Metastatic breast cancer remains largely incurable. Strategies involving the combination of the selective estrogen receptor modulator tamoxifen and chemotherapy have been abandoned in view of unacceptable toxicity because of thromboembolic
Autor:
Rosario, González-Mancha, Jose Jorge, Galán, Carmen, Crespo, Luis, Iglesias Pérez, Antonio, González-Perez, Francisco Jesús, Morón, José Andrés, Moreno Nogueira, Luis Miguel, Real, Manuel Hidalgo, Pascual, Agustin, Ruiz, Jose Luis, Royo
Publikováno v:
Medical science monitor : international medical journal of experimental and clinical research. 14(3)
Prolonged exposure to estrogens was found to be a risk factor for breast cancer. The molecular mechanism has been suggested to be the binding of estrogen receptors in mammary tissue, which promotes the proliferation of breast tissue. Different biomar
Autor:
M. Gil, May Alakl, K. Friedrichs, Stefan Korec, Euan Walpole, Simon Van Belle, Franco Buzzi, Stephen Chan, Gary Richardson, Istvan Bodrogi, Peter Simmonds, Elizabeth Murray, Michael Murawsky, Alessandro Riva, Monica Ronzoni, Tamás Pintér, Gunter von Minckwitz, Louise Yelle, Daniel Noel, John Crown, Rosario González Mancha, Daniel A. Vorobiof, Ricardo Duarte
Publikováno v:
Scopus-Elsevier
PURPOSE: This phase III study compared docetaxel and doxorubicin in patients with metastatic breast cancer who had received previous alkylating agent–containing chemotherapy. PATIENTS AND METHODS: Patients were randomized to receive an intravenous
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d8210b20af0301412b1ff227f2a1384
http://www.scopus.com/inward/record.url?eid=2-s2.0-0032787785&partnerID=MN8TOARS
http://www.scopus.com/inward/record.url?eid=2-s2.0-0032787785&partnerID=MN8TOARS